A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
Abstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies h...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-07-01
|
Series: | Nanoscale Research Letters |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s11671-019-3049-0 |
id |
doaj-9a47c1fd1e8944db8c46d66daf2a9c60 |
---|---|
record_format |
Article |
spelling |
doaj-9a47c1fd1e8944db8c46d66daf2a9c602020-11-25T03:36:42ZengSpringerOpenNanoscale Research Letters1931-75731556-276X2019-07-0114111110.1186/s11671-019-3049-0A Dual Targeting Magnetic Nanoparticle for Human Cancer DetectionSiwen Wu0Xiyu Liu1Jian He2Huiling Wang3Yiqun Luo4Wenlin Gong5Yanmei Li6Yong Huang7Liping Zhong8Yongxiang Zhao9National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityAbstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies have been performed to determine the role of lymphatic endothelial cells (LECs) in tumor metastasis. However, disadvantages such as non-specificity and high cost limit their research and diagnostic applications. In this study, Fe3O4@KCTS, a core-shell type of magnetic nanoparticles, was prepared by activating Fe3O4 with carbodiimide and cross-linking it with α-ketoglutarate chitosan (KCTS). The LYVE-1 and Podoplanin antibodies were then incorporated onto the surface of these magnetic nanoparticles and as a result, dual-targeting magnetic nanoprobes were developed. The experimental tests of this study demonstrated that a dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of LECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging.http://link.springer.com/article/10.1186/s11671-019-3049-0Lymphatic endothelial cellsPodoplaninLYVE-1Magnetic nanoparticles |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Siwen Wu Xiyu Liu Jian He Huiling Wang Yiqun Luo Wenlin Gong Yanmei Li Yong Huang Liping Zhong Yongxiang Zhao |
spellingShingle |
Siwen Wu Xiyu Liu Jian He Huiling Wang Yiqun Luo Wenlin Gong Yanmei Li Yong Huang Liping Zhong Yongxiang Zhao A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection Nanoscale Research Letters Lymphatic endothelial cells Podoplanin LYVE-1 Magnetic nanoparticles |
author_facet |
Siwen Wu Xiyu Liu Jian He Huiling Wang Yiqun Luo Wenlin Gong Yanmei Li Yong Huang Liping Zhong Yongxiang Zhao |
author_sort |
Siwen Wu |
title |
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection |
title_short |
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection |
title_full |
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection |
title_fullStr |
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection |
title_full_unstemmed |
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection |
title_sort |
dual targeting magnetic nanoparticle for human cancer detection |
publisher |
SpringerOpen |
series |
Nanoscale Research Letters |
issn |
1931-7573 1556-276X |
publishDate |
2019-07-01 |
description |
Abstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies have been performed to determine the role of lymphatic endothelial cells (LECs) in tumor metastasis. However, disadvantages such as non-specificity and high cost limit their research and diagnostic applications. In this study, Fe3O4@KCTS, a core-shell type of magnetic nanoparticles, was prepared by activating Fe3O4 with carbodiimide and cross-linking it with α-ketoglutarate chitosan (KCTS). The LYVE-1 and Podoplanin antibodies were then incorporated onto the surface of these magnetic nanoparticles and as a result, dual-targeting magnetic nanoprobes were developed. The experimental tests of this study demonstrated that a dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of LECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging. |
topic |
Lymphatic endothelial cells Podoplanin LYVE-1 Magnetic nanoparticles |
url |
http://link.springer.com/article/10.1186/s11671-019-3049-0 |
work_keys_str_mv |
AT siwenwu adualtargetingmagneticnanoparticleforhumancancerdetection AT xiyuliu adualtargetingmagneticnanoparticleforhumancancerdetection AT jianhe adualtargetingmagneticnanoparticleforhumancancerdetection AT huilingwang adualtargetingmagneticnanoparticleforhumancancerdetection AT yiqunluo adualtargetingmagneticnanoparticleforhumancancerdetection AT wenlingong adualtargetingmagneticnanoparticleforhumancancerdetection AT yanmeili adualtargetingmagneticnanoparticleforhumancancerdetection AT yonghuang adualtargetingmagneticnanoparticleforhumancancerdetection AT lipingzhong adualtargetingmagneticnanoparticleforhumancancerdetection AT yongxiangzhao adualtargetingmagneticnanoparticleforhumancancerdetection AT siwenwu dualtargetingmagneticnanoparticleforhumancancerdetection AT xiyuliu dualtargetingmagneticnanoparticleforhumancancerdetection AT jianhe dualtargetingmagneticnanoparticleforhumancancerdetection AT huilingwang dualtargetingmagneticnanoparticleforhumancancerdetection AT yiqunluo dualtargetingmagneticnanoparticleforhumancancerdetection AT wenlingong dualtargetingmagneticnanoparticleforhumancancerdetection AT yanmeili dualtargetingmagneticnanoparticleforhumancancerdetection AT yonghuang dualtargetingmagneticnanoparticleforhumancancerdetection AT lipingzhong dualtargetingmagneticnanoparticleforhumancancerdetection AT yongxiangzhao dualtargetingmagneticnanoparticleforhumancancerdetection |
_version_ |
1724548644403675136 |